Page last updated: 2024-11-02

picotamide and Cerebrovascular Disorders

picotamide has been researched along with Cerebrovascular Disorders in 3 studies

picotamide: has anticoagulant & fibrinolytic properties; structure

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research Excerpts

ExcerptRelevanceReference
") for secondary prevention of cerebral ischemia were compared with the effects of low-dosage aspirin (300 mg/die)."5.07[Clinical efficacy of picotamide]. ( de Falco, FA; Mastroroberto, G; Montariello, A; Visconti, OS, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Violi, F1
Criqui, M1
Longoni, A1
Castiglioni, C1
de Falco, FA1
Montariello, A1
Mastroroberto, G1
Visconti, OS1
Speziale, F1
Taurino, M1
Colella, E1
Rizzo, L1
Fiorani, P1

Trials

2 trials available for picotamide and Cerebrovascular Disorders

ArticleYear
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Atherosclerosis, 1996, Volume: 120, Issue:1-2

    Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Dis

1996
[Clinical efficacy of picotamide].
    La Clinica terapeutica, 1991, Jul-15, Volume: 138, Issue:1

    Topics: Adult; Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Tr

1991

Other Studies

1 other study available for picotamide and Cerebrovascular Disorders

ArticleYear
[Clinical study of picotamide in patients with vascular diseases].
    Recenti progressi in medicina, 1989, Volume: 80, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cerebrovascular Disorders; Drug Evaluat

1989